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ABSTRACT
Rose Le: Artificial De Novo Tetramer Hydrogenase Mimic, Co-Metallopeptide Design,
Titration, and Photocatalysis
(Under the direction of Dr. Saumen Chakraborty)
Alternative energy is more imperative than ever as we continue to exhaust nonrenewable
resources. There is promise in artificial hydrogenases that produce hydrogen gas which can be an
alternate source of clean, sustainable renewable energy. Moreover, artificial metalloenzymes
were designed for solar H2 production using de novo designed metallopeptides. A computer
guided design approach was used to conceive the peptides. These peptides are 30 amino acids
long and are designed to self-assemble into tetrameric structures. There are suitably positioned
cysteine residues that bind the metal Co and form metallic clusters within these artificial
proteins. The Co-metallopeptides were then characterized by employing spectroscopic
techniques. They were found to have varying binding activity and optimal photocatalytic activity
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Fossil Fuels like coal, crude oil, and natural gases will not only be completely depleted
one day, but also, they produce CO2 that contributes to environmental pollution and climate
change. [1] Increases in atmospheric CO2 due to human activities are at an all time high. [2]
Moreover, the search for an alternative fuel source that is cleaner and more sustainable is more
crucial than ever. H2 can be combined in a fuel cell with O2 to produce heat and electricity to
perform work. The byproduct, H2O, is nontoxic; therefore, hydrogen gas is a promising
alternative source of renewable and clean energy. Hydrogenases serve as inspiration for
synthesizing catalysts that produce hydrogen gas by reduction of H+ efficiently. However, many
hydrogenases can have dangerous O2 reactivity and low production yield. The solution and goal
is to one day be able to harvest solar energy via artificial photosynthesis and artificial metallo
hydrogenases to catalyze the reduction of H+ to H2.
The goal is to have chemical molecules harvest solar energy from the sun and separate
charges. The oxidizing and reducing equivalents from the chemical molecules can then provide
the de novo catalysts with equivalents for H2O oxidation to O2 and H+ reduction to H2 (Figure
2). If 10% efficient solar cells covered just 0.16% of Earth’s land, approximately 20 TW of
energy of the 120000 TW of available energy from sunlight, can be made. This is projected to
meet the demands of this century.[10]
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Figure 2: Sunlight harvested to provide charges for electron donors and acceptors to exchange
with artificial de novo hydrogenase mimic as a catalyst yielding H2 in a reversible reaction (2e- +
2H+↔ H2).
1.2 Biosynthetic Approach to Hydrogen evolution catalyst
There has been ample studies conducted and are underway to better understand native
hydrogenases. [3a-d] This better understanding of native hydrogenases helps develop molecular
catalysts analogous to hydrogenases that use earth abundance transition metals and perform as
electrolytic and photocatalytic hydrogen evolution reaction (HER) catalysts. Because most of
these molecular catalysts require very acidic conditions and are soluble in organic solvents,
active site metals are supported with protein or peptide scaffolds so that they can be studied in
water. This is possible because it mimics the protein environment. [4] Acidic to basic residue
substitutions enables remote hydrogen bonding to improve activity by facilitating H+ transfer to
the active site.[5] Some current models for HER Catalyst are i) self-assembly of photosystem I
with well-known molecular catalysts; ii) synthetic catalysts attached to peptides; iii) substi-
11
tution of native cofactors from proteins with non-native metal- lic cofactors;  iv) substitution of
native metal bound to endoge- nous ligands in an ET protein with non-native metals; and v)
repurposing a copper storage protein to a Ni binding protein. [6] The model that will be further
studied in this thesis is a reengineered and de novo protein that will mimic naive hydrogenases
like a sulfate reducing bacteria from the Desulfovibrio species.
Figure 3: Two binuclear active sites found in hydrogenase enzymes of microorganisms that
produce H2.. A. [NiFe] Hydrogenase active site from sulfate reducing bacteria, Desulfovibrio
species B.[FeFe] Hydrogenase active site from nitrogen fixing bacteria, Clostridium
pasteurianum (Cp) . The Ni active site is of particular interest in current studies.
Chapter 2: De Novo Tetramer
2.1 Background
The de novo tetramer is an attempt to characterize artificially-designed α-helical tetramer
barrels and furthering understanding of protein repertoires. This exploration’s main aim is to rely
on the known sequence-to-structure relationships of the α-helical coiled coil7,8 to further
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knowledge of peptide engineering so as to inform future research efforts in the determination of
potential applications in the fields of synthetic biology or biotechnology. Additionally, this
α-helical tetramer’s interactions with earth abundant transition metals nickel, iron, and cobalt are
being studied.
In order to follow along, one must first have the foundational understanding of proteins.
Proteins are amino acids that are chained together, and the chain of amino acids corresponds to
the DNA sequence of a gene that encodes it. This chain is created by condensation reactions to
form peptide bonds which cumulatively comprise a chain of amino acids also known as a
peptide’s primary sequence, an example of which is visualized in the synthesis of the dipeptide
below (Figure 4). 9
Figure 4: Creation of a dipeptide. A water molecule is formed with one hydrogen from an amine
group and one hydroxyl from a carboxylic acid group. In the figure, water components are blue,
and  the covalent peptide bond components are red.9
As more amino acids are condensed to elongate the peptide chain, the peptide backbone’s amide
hydrogens and carbonyl oxygens can induce hydrogen bonding the results in secondary
structures like α-helices or β-pleated sheets. These secondary structures have β-turns, or Ω-coils.
The a α-helices or β-pleated sheets are integral in the design and study of the proteins in this
thesis.
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There is already ample understanding of coiled-coil α-helices sequence-to-structure relationship
due to the deduction of patterns like hydrophilic (P) and hydrophobic (H) residues typically in a
seven-unit heptad repeat (HPPHPPP)n . These repeats can also be referred to as abcdefg, and
positioned in helical wheels of an α-helix (Figure 5).10
Figure 5: Heptad repeat sequence abcdefg displaced around an α-helix in a helical wheel.
Shaded darker are the residues closer to the helix interface.
Moreover, α-helices with this heptad repeat can have intramolecular interactions with
other α-helices of the same heptad repeat through side chains known as knob-into-holes (KIH)
packing.10,11 The hydrophilic and hydrophobic heptad repeat and KIH packing is the basis of how
these coiled-coil α-helices can be realistically designed 14, 15 and via computation. 11, 12, 13
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This translates to how the De Novo Tetramer was able to be designed and be viable for
further investigation. The De Novo Tetramer is overall composed of four α-helices arranged
about a central axis to create an inner region of open space which may be used for metal binding.
The monomers that compose the tetramer’s α-helices are 30 residues long, have a molecular
weight of 3301.91 g/mo,l and a theoretical pI of 6.36. The de novo tetramer’s primary sequence
contains two Cys residues which when utilized in conjunction with the protein’s tetramer
structure results in eight Cys residues arranged in a metal-binding pocket. SC01’s primary
sequence is Ac-GLAAIEQKCEACEKKLEAIEKKLAAIEWKG-CONH2, and its helical
wheel is represented in Figure 6, and 3D models of the protein’s tertiary structure are visualized
in Figure 7.
Figure 6: De novo tetramer helical wheel.
15
Figure 7: SC-01’s four α-helices arranged so their individual Cys residues form a central pocket
for potential transition metal binding.
2.2 Synthesis and Purification Procedure
Peptide synthesis was done by standard Fmoc SPPS protocols on a CEM LibertyBLUE
microwave-assisted automated peptide synthesizer (CEM Corporation, Buckingham, UK).
Peptides were synthesized on a Rink amide ChemMatrix resin (PCAS Biomatrix, Quebec,
Canada) by taking advantage of HBTU activation. After automated synthesis, peptide acetylation
using acetic anhydride and pyridine in DMF was performed. The crude peptide was then cleaved
from the resin by treatment with a 95:2.5:2.5 mix of trifluoroacetic acid:water:triisopropylsilane
for 2 hours at room temperature. The cleavage mixture was then dripped into ten times the
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volume of 0°C diethyl ether, and the precipitate that formed was isolated by centrifugation. The
solid was dissolved in a 1:1 mix of water and acetonitrile and freeze-dried to give the crude
peptide. This material was purified using reversed-phase HPLC using a C18 column (10 × 150
mm, Kromatek, UK) and running a gradient from 20 % to 80 % acetonitrile in water over 30
minutes.
Figure 8: High Performance Liquid Chromatography (HPLC) System.
17
Figure 9: Vacuum under fume hood to dry purified peptide.
Chapter 3: Co-metallopeptide De Novo Tetramer Titration
3.1 Background
Current efforts to characterize the de novo tetramer include determining how the tetramer
interacts and binds with transition metals. Studies have shown that this Nickel is able to bind to
this tetramer within the cysteine binding pocket 3 times and yield hydrogen gas in photocatalysis
assays. However, there has been no data on how this de novo tetramer will interact with Cobalt.
In order to determine if Cobalt will bind with this Artificial De Novo Tetramer, titrations of
varying cobalt equivalences were performed with dissolved de novo tetramer and read on a
spectrometer.
This spectroscopy works by emitting a light through a cuvette, and depending on the
substance, there will be varying absorbance of the light. The resulting intensity is measured on
the other side. For a wider range of wavelengths, the spectrometer needs a collimator to transmit
the light in a linear beam to the monochromator. The monochromator is what will split the light
18
into different wavelengths, and a slit will only allow desired wavelengths to be transmitted
through the sample and detected by the photometer.16
Figure10: Structure of most spectrophotometers.
The absorbances come from taking the log of the measured intensity over the initial intensity,
also known as transmittance. Absorbance can be further determined by Beer Lambert’s Law
(Equation 1).
Equation 1: Beer Lambert's Equation relates absorbance to the extinction coefficient times
concentration times the path length.
Absorbances will be gathered for ascending equivalences of CoCl2 added to the de novo
tetramer until it is saturated. The equivalences in which the de novo tetramer staturates will be
utilized for further studies like photocatalysis.
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3.2 Co-metallopeptide Titration Procedure
In order to perform the spectrometric Co-metallopeptide titration to characterize any
binding activity cobalt and the De Novo Tetramer may have, a diluted cobalt solution and de
novo tetramer solution must be prepared first. A CoCl2 metal solution must also be diluted with
and degassed with N2 for 5-10 minutes to ensure an anaerobic environment. The Cobalt solution
was made by adding 2.5 µL of a 1M CoCl2 stock with 997.5 µL of distilled H2O for a 2.5 mM
CoCl2 solution. Next, the de novo tetramer random stock was made by adding frozen purified
peptide to 500µL of 0.1M tris buffer. After setting the blank on the spectrometer with 100 µL of
0.1M tris buffer, 1µL of the random stock of the De Novo Tetramer was diluted with 99 µL 0.1M
tris buffer in a cuvette and was read in the spectrophotometer at 280nm - 800nm. The
concentration of the peptide was used to calculate how many microliters of the peptide stock
must be added in the peptide APO solution for a final peptide concentration of 100 µM peptide
in 2500 µL solution. The solution will contain the peptide, of Tris (2-carboxyethyl) phosphine
(TCEP) [to reduce disulfide bonds], and 0.1M tris buffer [to deprotonate the cysteines]. While
this APO solution is degassed with N2 for 4-5 minutes maximum in order to prevent evaporation
of the solution, two blanks of just 2487.5 µL of 0.1M tris buffer and 12.5 µL TCEP were made.
One blank was to match the solution volume of the Co-metallopeptide solution as the solution is
titrated, and the other blank is to match the ending volume of the titrated Co-metallopeptide
solution to read at the end of the titration. This is to ensure that what activity is seen is from the
metal binding and not from the peptide alone.
To determine the volume of one equivalence of cobalt, the apo was read in the
spectrophotometer and then divided by 4. 0.1 eV added at a time, then 0.2 eV, then 0.3 eV, and
finally 0.5 until the de novo tetramer was fully saturated.
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Figure 11: Vial coloration visibly changed from before (left) to after (right) the titration.
3.3 Titration Results
The first titration performed on 8/31/2020 can be seen in figures 12,13 and 14. Overall the
titration was successful. Predicted and typical features were seen at wavelengths 315, 360, 640,
688, and 720 nm. Saturation began around 3 equivalences.
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Figure 12: Absorbance v. Wavelength (nm) graph for equivalences from 0.1 to 4.7.
Figure 13: Difference in absorbances v. Co Equivalence overlay graph of absorbances 315, 360,
640, 688, and 720 nm.
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Figure 14: Difference in absorbances v. Co Equivalence overlay graph of absorbances 315, 360,
640, 688, and 720 nm.
The titration performed on 9/10/2020 can be seen in figures 15,16 and 17. At wavelengths  312
and 356 nm, saturation occurred at around 2 equivalences. There were weird transitions spotted
about 1.2 equivalences for wavelength 640 nm and from 1.5 to 45 equivalences for wavelength
690 nm and 720 nm. that were not present in the first titration.
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Figure 15: Absorbance v. Wavelength (nm) graph for equivalences from 0.1 to 5.2.
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Figure 16: Difference in absorbances v. Co Equivalence overlay graph of absorbances 312, 360,
640, 690, and 720 nm.
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Figure 17: Difference in absorbances v. Co Equivalence overlay graph of absorbances 312, 360,
640, 690, and 720nm.
The titration performed on 9/17/2020 can be seen in figures 18, 19 and 20. At wavelengths 315
nm and 350 nm saturation occurred at around 1.5 equivalences. A tiny feature is present around
1.5 equivalences for wavelength 315. Odd transitions were also spotted  again at wavelength 640
nm, but they were not similar to the other two titrations.
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Figure 18: Absorbance v. Wavelength (nm) graph for equivalences from 0.1 to 3.6.
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Figure 19: Difference in absorbances v. Co Equivalence overlay graph of absorbances 315, 350,
640, 690, and 720 nm.
Figure 20: Difference in absorbances v. Co Equivalence overlay graph of absorbances 315, 350,
640, 690, and 720 nm.
The titration performed on 10/08/2020 can be seen in figures 21, 22 and 23. At wavelengths
310 nm and 360 nm saturation occurred at between 1.5 and 2 equivalences. Odd features are all
throughout the entire curve. There was also a new tiny feature at wavelength 920 nm.
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Figure 21: Absorbance v. Wavelength (nm) graph for equivalences from 0.1 to 3.9.
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Figure 22: Difference in absorbances v. Co Equivalence overlay graph of absorbances 310, 360,
640, 690, and 720 nm.
Figure 23: Difference in absorbances v. Co Equivalence overlay graph of absorbances 310, 360,
640, 690, and 720 nm.
The titration performed on 11/16/2020 can be seen in figures 24, 25 and 26. At wavelengths
310 nm and 360 nm saturation occurred at between 1.5 and 2 equivalences. Features are all
throughout the entire curve at wavelengths 315, 360, 640, 690, and 720 nm.
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Figure 24: Absorbance v. Wavelength (nm) graph for equivalences from 0.1 to 4.2.
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Figure 25: Difference in absorbances v. Co Equivalence overlay graph of absorbances 310, 350,
640, 690, and 720 nm.
Figure 26: Difference in absorbances v. Co Equivalence overlay graph of absorbances 310, 350,
640, 690, and 720 nm.
Chapter 4: Photocatalysis
4.1 Background
After determining how the metal binds with the peptide, photocatalysis assays are able to
be performed to determine if there is hydrogen gas production and the best parameters for
optimal hydrogen gas production. Photocatalysis is the use of light to excite a photosensitizer
and exchange electrons with a sacrificial electron donor like ascorbic acid and an acceptor like
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our transition metals to catalyze a reaction (Figure 28) . The reaction in this case is the reduction
of H+ ions into H2. Photocatalysis is the activity occurring when a light source interacts with the
surface of semiconductor materials, the so called photocatalysts. During this process, there must
be at least two simultaneous reactions occurring, oxidation from photogenerated holes, and
reduction from photogenerated electrons. The photocatalyst itself should not undergo change and
therefore a precise synchronisation of the two processes needs to take place. Fujishima and
Honda first achieved an electrochemical photocatalysis of water at a semiconductor electrode in
1972. 18
4.2 Photocatalysis Procedure
The three main ingredients for performing photocatalysis are an electron donor (ascorbic
acid), photosensitizer (Ruthenium Bipyridine), and the electron acceptor/catalyst
(Co-metallopeptide). How much hydrogen gas produced will be measured with a Gas
Chromatography, GC tracer. The GC tracer is prepared 20 minutes before use by ensuring that
the air, N2, and H2 twisted open, that the GC tracer is turned on, and that power is on 180 mV.
Once the Ruthenium Bipyridine and Ascorbic Acid is made, and 1mM of Ruthenium Bipyridine
and 100mM Ascorbic Acid are weighed out, they must each be degassed for approximately 8
minutes with N2. To make the metal-peptide at a desired molarity of 1500 µM in 300 µL, how
much of the peptide stock must be added into the peptide solution must be calculated. The
concentration of the peptide stock must be determined by reading a sample of the peptide stock
in Tris buffer. 100 µL of 10 M tris buffer was added into a cuvette and used as the blank. Then,
10µL of the peptide stock and 90µL of 0.1M tris buffer was added to a second cuvette to be read
in the spectrophotometer. The volume of the peptide stock was determined by C1V1=C2V2,
1800µM x Vol. of Peptide Stock (µL) = 1500µM x 300 µL. The concentration of TCEP that will
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be added to the peptide solution was calculated by multiplying 50 by the desired end
concentration of peptide (1500µM x 50 = 75 mM TCEP), and the volume of TCEP that will be
added to reduce the peptide solution was calculated also by C1V1=C2V2, 1000 mM x Vol. µL =
75 mM x 300 µL, yielding 22.5 µL TCEP that must be added to the peptide solution. The
reduced peptide was then eluted out with a size exclusion chromatography PD-10 desalting
column with sephadex G25 resin. After the column was saturated with 2.5 mL of  the peptide
solution, 3.5 mL of 10 M tris buffer was added to elute the reduced protein without TCEP.
Figure 27: PD-10 desalting column with Sephadex G25 resin to size exclude TCEP out
of our reduced peptide.
After the appropriate volumes peptide stock and 10 M tris buffer were added to make the
300 µL peptide solution; it was degassed with N2 for 5 minutes, and stirred for 10 minutes. Next,
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because we know that Cobalt has maximum binding affinity at around 2 equivalences, we were
able to calculate the volume of CoCl2 ( µL) that will be going in the metal-peptide solution. If we
have 1500  µM monomers, that means that we have 375 µM of tetramer. (3.75  µM x 2 eV  300
µL)/ 50,00 µM CoCl2 which should be about 7 µL of CoCl2 that will be added into the
metal-peptide solution. The metal will be added in 1.5 µL at a time and stirred for 5 minutes to
prevent precipitation.
To determine how much volume of the metal-peptide solution that will be going in the
photocatalysis solution, the formula C1V1=C2V2 was used again. Since the metal-peptide
solution was made to be at a concentration of 1500 µM, and the desired final concentration and
volume is 50 µM and 2300 µL; 80µL of the metal-peptide solution should be combined with
2220 µL of 0.1M tris buffer in a tube of pre-weighted amounts of Rubidium and Ascorbic Acid.
A little bit more than 2 mL of that will be aliquoted into the tube in which photocatalysis will be
taking place. A metal stir bar was already placed in the photocatalysis tube, and a cap will cover
the tube as well as a layer of parafilm. The tube will then be degassed with N2 until it is reduced
to 2 mL. The tube will be suitably placed on a stand above a stirrer and in the path of the light to
cover the entire volume in the tube. Every 30 minutes, a syringe is used to extract about 3 mL of
gas and is taken to the GC tracer to be read. After the syringe is reduced to 2.5 mL and cleaned
with ether, it is inserted in the GC tracer for a reading. Readings are taken every 30 minutes until
H2 gas production begins to saturate off. The syringes are degassed between each reading.
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Figure 28: Photocatalysis reaction set up. The solution is constantly stirred and sealed from the
air while light beams on the solution.
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Figure 29: Ruthenium bipyridine excitation leads to ascorbic acid stepping in as a sacrificial
electron donor, then Co(II)-De Novo Tetramer serving as an electron acceptor. Co(I)-De Novo
Tetramer returns to stable state, Co(II)-De Novo Tetramer, by reduction of 2H+ to H2.
4.3 Photocatalysis Results
Seen in figure 30, figure 31, figure 32, are TON vs. time (hours) graphs for pH 4, 5, and
6.3 for light drive H2 production by Co-De Novo Tetramer. The overlay graph for these TON
versus time (hours) of these pH’s is in figure 33. H2 gas production that begins saturating after 3
hours, 3.5 hours, and 3 hours for pH 4, 5 and 6.3, respectively. The greatest TON is seen at pH 5.
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Figure 30: Turnover number versus time (hours) for light driven H2 production at pH 4.
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Figure 31:Turnover number versus time (hours) for light driven H2 production at pH 5.
Figure 32:Turnover number versus time (hours) for light driven H2 production at pH 6.3.
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Figure 33: TON versus time (hours) overlay graph for light driven H2 gas production
from de novo tetramer hydrogenase mimic at pH 4, 5, and 6.3.
40
Figure 34: TON versus pH graph for light driven H2 gas production from de novo
tetramer hydrogenase mimic.
Chapter 5: Conclusion
5.1 Conclusion and Future Directions
In summary, we are inching closer and closer towards better understanding the repertoires
of protein structures and optimizing metallopeptide artificial hydrogenases for viable energy
from hydrogen gas. We must remain vigilant in our efforts to characterize these proteins and
enzymes as nonrenewable resources are being exhausted everyday. Current efforts to
characterize the de novo tetramer are directed toward condition optimization such as pH. For
Cobalt with the De Novo Protein, there is varying binding activity that averages near 2
equivalences. With 2 equivalences the Co-De Novo Tetramer, the most TON of hydrogen gas
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produced out of the pH’s studied was at pH 5. We are well on our way to completing more
photocatalysis assays to determine the best parameters for optimal H2 production with Nickel,
Iron, and Cobalt. Future directions would also include investigating the mechanism for H2
production utilizing fluorescence emission and transient spectroscopy.
42
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